State of Wisconsin Investment Board’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,078
Closed -$154K 2542
2022
Q4
$154K Sell
1,078
-69
-6% -$17.2K ﹤0.01% 2286
2022
Q3
$261K Buy
+1,147
New +$291K ﹤0.01% 2291
2022
Q2
Sell
-1,750
Closed -$559K 2791
2022
Q1
$559K Buy
+1,750
New +$403K ﹤0.01% 1774
2020
Q1
Sell
-201
Closed -$34K 1695
2019
Q4
$34K Hold
201
﹤0.01% 1615
2019
Q3
$199K Buy
201
+107
+114% +$119K ﹤0.01% 1503
2019
Q2
$107K Buy
94
+2
+2% +$1.81K ﹤0.01% 1517
2019
Q1
$70K Buy
+92
New +$83.6K ﹤0.01% 1523

Other funds holding ACET

State of Wisconsin Investment Board's ACET Position: Q1 2023 in Review

State of Wisconsin Investment Board sold out of Adicet Bio (ACET) in Q1 2023, closing a stake of 1,078 shares — an estimated $154K sold.

State of Wisconsin Investment Board first reported a position in ACET in Q1 2019 and held it in 7 quarters. The position peaked at $559K in Q1 2022. 107 funds tracked by Wall St. Rank hold ACET as of Q1 2023.

  • State of Wisconsin Investment Board reported no remaining Adicet Bio position as of Q1 2023 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 1,078 Adicet Bio shares in Q1 2023, an estimated $154K.
  • State of Wisconsin Investment Board first reported a position in Adicet Bio in Q1 2019 and held it in 7 quarters.
  • State of Wisconsin Investment Board's Adicet Bio position peaked at $559K in Q1 2022.
  • 107 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2023, filed 15 May 2023.